India too should look into mixed dose regime trial, says NITI Aayog member
The Hindu
If proven effective it could go a long way in enhancing faster coverage: V.K. Paul
India can be looking at initiating trials for interchangeability of different COVID-19 vaccines for use to enhance the efficiency of vaccines and offer longer protection, said a senior health official on Monday, while stating that there is currently no specific time line projected for the trials. Speaking about the possibility of a mixed dose regime trial, NITI Aayog member (Health) V.K. Paul said: “There is growing scientific interest in the matter world-wide and India too should look into it. This is a biological plausibility and if proven effective it could go a long way in enhancing faster coverage and acting as a better booster dose that can be offered for use.” Dr. Paul, however, said he wasn’t aware of any specific dates for trial of the proposed regime.More Related News